Alnylam Announces Pandemic Flu as Next Development Program; Gets DoD Funding

Dec 14, 2005

NEW YORK, Dec. 14 (GenomeWeb News) - With initial funding from the Department of Defense, Alnylam Pharmaceuticals will advance its pandemic flu project into a development program, the company announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Concentration of Rare Disease

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Unexpected Findings

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Make it a Bit Fuzzy

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

This Week in Science

In Science this week: approach to visualize chromatin structure in nuclei, and more.

Main menu